» Articles » PMID: 32071038

The Effect of Training GPs in Motivational Interviewing on Incident Cardiovascular Disease and Mortality in People with Screen-detected Diabetes. Results from the ADDITION-Denmark Randomised Trial

Overview
Journal BJGP Open
Specialty Public Health
Date 2020 Feb 20
PMID 32071038
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Background: There is no long-term evidence on the effectiveness of training for motivational interviewing in diabetes treatment.

Aim: Within a trial of intensive treatment of people with screen-detected diabetes, which included training in motivational interviewing for GPs, the study examined the effect of the intervention on incident cardiovascular disease (CVD) and all-cause mortality.

Design & Setting: In the ADDITION-Denmark trial, 181 general practices were cluster randomised in a 2:1:1 ratio to: (i) to screening plus routine care of individuals with screen-detected diabetes (control group); (ii) screening plus training and support in intensive multifactorial treatment of individuals with screen-detected diabetes (intensive treatment group); or (iii) screening plus training and support in intensive multifactorial treatment and motivational interviewing for individuals with screen-detected diabetes (intensive treatment plus motivational interviewing group). The study took place from 2001-2009.

Method: After around 8 years follow-up, rates of first fatal and non-fatal CVD events and all-cause mortality were compared between screen-detected individuals in the three treatment groups.

Results: Compared with the routine care group, the risk of CVD was similar in the intensive treatment group (hazard ratio [HR] 1.11, 95% confidence interval [CI] = 0.82 to 1.50) and the intensive treatment plus motivational interviewing group (HR 1.26, 95% CI = 0.96 to 1.64). The incidence of death was similar in all three treatment groups.

Conclusion: Training of GPs in intensive multifactorial treatment, with or without motivational interviewing, was not associated with a reduction in mortality or CVD among those with screen-detected diabetes.

Citing Articles

The MIPAM trial: a 12-week intervention with motivational interviewing and physical activity monitoring to enhance the daily amount of physical activity in community-dwelling older adults - a study protocol for a randomized controlled trial.

Larsen R, Korfitsen C, Juhl C, Andersen H, Christensen J, Langberg H BMC Geriatr. 2020; 20(1):412.

PMID: 33081715 PMC: 7576698. DOI: 10.1186/s12877-020-01815-1.

References
1.
Perk J, De Backer G, Gohlke H, Graham I, Reiner Z, Verschuren M . European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted.... Eur Heart J. 2012; 33(13):1635-701. DOI: 10.1093/eurheartj/ehs092. View

2.
Sortso C, Komkova A, Sandbaek A, Griffin S, Emneus M, Lauritzen T . Effect of screening for type 2 diabetes on healthcare costs: a register-based study among 139,075 individuals diagnosed with diabetes in Denmark between 2001 and 2009. Diabetologia. 2018; 61(6):1306-1314. PMC: 7617192. DOI: 10.1007/s00125-018-4594-2. View

3.
Rubak S, Sandbaek A, Lauritzen T, Borch-Johnsen K, Christensen B . An education and training course in motivational interviewing influence: GPs' professional behaviour--ADDITION Denmark. Br J Gen Pract. 2006; 56(527):429-36. PMC: 1839017. View

4.
Rubak S, Sandbaek A, Lauritzen T, Borch-Johnsen K, Christensen B . General practitioners trained in motivational interviewing can positively affect the attitude to behaviour change in people with type 2 diabetes. One year follow-up of an RCT, ADDITION Denmark. Scand J Prim Health Care. 2009; 27(3):172-9. PMC: 3413190. DOI: 10.1080/02813430903072876. View

5.
Lauritzen T, Griffin S, Borch-Johnsen K, Wareham N, Wolffenbuttel B, Rutten G . The ADDITION study: proposed trial of the cost-effectiveness of an intensive multifactorial intervention on morbidity and mortality among people with Type 2 diabetes detected by screening. Int J Obes Relat Metab Disord. 2000; 24 Suppl 3:S6-11. DOI: 10.1038/sj.ijo.0801420. View